This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ChatGPT shows potential for diagnosing nuclearmedicine cases, yet needs further development before it can be implemented in practice, according to a study presented November 28 at RSNA in Chicago. and ChatGPT-4 to the test on nuclearmedicine differential diagnoses cases transcribed from two textbooks.
TORONTO – Clinician-scientists can do much to advance nuclearmedicine, but it will take passion and stamina to succeed, said Ora Israel MD, at the annual meeting of the Society of NuclearMedicine and Molecular Imaging (SNMMI). Clinical research involves a different perspective. Wagner Lecture on June 7.
The recommendations could improve patient care, as current clinical tools are often insufficient in complicated cases, noted lead author of the guidance Jamieson Bourque, MD, of the University of Virginia Health System in Charlottesville. The recommendations emphasize the complementary nature of these advanced nuclearmedicine exams.
While academic medical center radiology departments are expanding significantly and hospitals are adapting to health system consolidation trends, demand for innovative imaging informatics remains strong among operations and physician teams. billion healthcare facility. Another, a new hospital complex is underway at University of Utah Health.
F-18 fluoroestradiol (FES)-PET scans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. Image and caption courtesy of the RSNA. The full study is available here.
The finding is from a preliminary analysis of 23 patients enrolled in an ongoing clinical trial, noted Giorgio Brembilla, MD, PhD, of the IRCCS San Raffaele Scientific Institute in Milan, Italy. The combination of PSMA-PET and MRI could improve the detection of clinically significant cancer in clinically high-risk patients, he concluded.
The study was published February 13 in the Journal of NuclearMedicine. Ga-68 FZ-NR-1 PET/CT images and F-18 FDG PET/CT and PET/MRI images in representative nectin-4-positive TNBC patients. (A) A) PET/CT images and nectin-4 immunohistochemistry (IHC) staining of patient 1.
The world’s top nuclearmedicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma breast cancer, with the document released May 14 in the European Journal of NuclearMedicine and Molecular Imaging. The full article is available here.
A significant percentage of imaging studies ordered by office-based healthcare providers are self-interpreted rather than referred to radiologists for reading, according to researchers from the Harvey L. million office-based imaging claims for Medicare fee-for-service beneficiaries in 2022 that were ordered by nonradiologists.
and European experts have proposed a joint practice guideline for use in nuclearmedicine on diagnostics and therapy (theranostics) of meningiomas, as published June 20 in the European Journal of NuclearMedicine and Molecular Imaging. the group wrote. or European medical agencies, they added.
Researchers at the University of Zurich in Switzerland say they have produced the first cinematically rendered image from a patient based on a standard clinical F-18 FDG-PET/MRI scan. The article was published on July 1 in the European Journal of NuclearMedicine and Molecular Imaging and featured as the journal's Image of the Month.
It's been really neat for us to not only have the beneficial reuse, where we're offsetting the cost of the American taxpayer, but you're actually seeing something pretty cool come out of it in nuclearmedicine space, explained OREM manager Jay Mullis.
Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. His lab team is currently focused on "implementing advanced techniques, such as parallel transmit, to achieve more consistent image quality and fully harness the power of 7T for every patient," Middlebrooks said.
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. There's a huge role for AI in image acquisition," he said.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclearmedicine, diagnostic radiology, and radiation oncology.
Medical students prefer musculoskeletal, body, and breast imaging early in their clinical education, according to research published October 19 in Current Problems in Diagnostic Radiology. The four-week radiology rotation involves didactic teaching for different imaging techniques and modalities. 0.001 Body imaging 30.2%
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new guidelines on their use can help pave the way to improved outcomes for patients, experts noted in a recent article. The article was published October 10 in the Journal of NuclearMedicine.
PET/CT imaging with F-18 fluroestradiol (FES) can play a significant role helping clinicians make treatment decisions in patients with recurrent or metastatic breast cancer, according to a study published October 3 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We Nuclear Regulatory Commission and is an integral part of a theranostics practice.
Offering both anatomic and functional imaging, NeuSight PET-CT supports a wide range of molecular imaging applications, according to the company. Positron provides PET and PET-CT imaging systems and clinical services to nuclearmedicine healthcare providers throughout North America.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.
Fibroblast activation protein inhibitor (FAPI)-PET/CT appears superior to standard FDG-PET/CT for detecting gastrointestinal cancer, with higher radiotracer uptake seen in most tumors, according to a study published October 26 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. A) Maximum-intensity-projection PET images.
The finding suggests that PET imaging of translocator protein (TSPO) in the brain can serve as a biomarker for evaluating patients whose disease progresses despite treatment, noted lead author Tarun Singhal, MD, of Brigham and Women’s Hospital and colleagues. Image courtesy of ClinicalNuclearMedicine.
In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of NuclearMedicine. PET/CT and MR images of a 72-year-old woman. (A)
milla1cf Tue, 06/11/2024 - 18:49 June 11, 2024 — The Society of NuclearMedicine and Molecular Imaging recognized six new SNMMI Fellows during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. It is among the most prestigious formal recognitions available to long-time SNMMI members.
FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of NuclearMedicine. They found high detection rates and diagnostic accuracy, as well as superior performance to standard imaging. Patient denied recommended chemotherapy.
Urbain, MD, PhD, FASNC , professor of radiology/nuclearmedicine and medicine, vice chair of theranostics, and director of nuclearmedicine at Roswell Park Cancer Center at the University of Buffalo , Buffalo, New York. and ‘How can we ensure diversity in all parts of the nuclearmedicine family?’
New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting.
F-18 FAPI-PET/CT is superior to F-18 FDG-PET/CT for diagnosing and staging patients with pancreatic cancer, according to a study published January 4 in the Journal of NuclearMedicine. In the future, F-18 FAPI-04 PET/CT may play a greater role in the actual clinical management of PDAC,” the group wrote.
A new PET radiotracer has the potential for visualizing responses in liver cancer patients undergoing immunotherapy, according to a study published December 12 in the Journal of NuclearMedicine. Thus, in this study, the group synthesized F-18 AlF-NOTA-BCP137 and first evaluated it using micro-PET/CT imaging in mice with tumors.
We highlight some of the recent accomplishments in research and clinical trials by members of the department who apply nuclearmedicine to diagnose and treat illnesses including cancer.
Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly.
PET/CT imaging with F-18 sodium fluoride (NaF) is emerging as a sensitive tool for detecting early atherosclerosis, according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting. The patients ranged in age from 21 to 75 years old.
the RSNA Mahmood's primary research for the past 30 years has been in molecular imaging and its application to guide precision medicine. At MGH in Boston, he currently serves as chief of nuclearmedicine and molecular imaging, overseeing the service for multiple hospitals and facilities in the region.
Proposed criteria for F-18 fluoromisonidazole (FMISO) PET imaging can help clinicians manage patients with head and neck cancer (HNC), according to a group at Memorial Sloan Kettering Cancer Center in New York City. The study was published on September 12 in the Journal of NuclearMedicine. A graphical abstract of the study.
An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of NuclearMedicine and Molecular Imaging Annual Meeting (SNMMI). Comparative analysis involved PET/CT parameters of both tracers.
reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclearmedicine, and radiation oncology. providers and the entire cardiac imaging community,” said Ahmad Slim, MD, chair of the SCCT Health Policy and Practice Committee.
Pluvicto (lutetium-177 [Lu-177] prostate-specific membrane antigen [PSMA]-617) appears to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval, according to clinicians at the Johns Hopkins Theranostics Center in Baltimore, MD. treatment center.
“This is a potentially practice-changing trial,” said Oliver Sartor, MD, a medical oncologist and director of radiopharmaceutical trials at the Mayo Clinic in Rochester, MN. He presented the abstract on behalf of first author Ken Herrmann, MD, chair of nuclearmedicine at the University Hospital Essen in Essen, Germany.
A feasibility study could could revive interest in SPECT seizure imaging to help neurosurgeons guide brain surgery in epilepsy patients, according to a team in Switzerland. The article was published January 11 in the Journal of NuclearMedicine. We used this untapped opportunity to image planned seizures,” they wrote.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content